FDA Says Defibrillator Defects Increasing

The number of defects present in implantable defibrillators is rising at a dangerous pace, according to joint research Harvard Medical School and
the Food and Drug Administration. The study suggests that the recent recalls by defibrillator manufacturers such as Guidant, Medtronic, and St. Jude’s Medical point toward a growth in the number of defibrillator defects. Additionally, they also state that defibrillator replacements due to these defects has decreased, showing that even though the number of defective devices are rising, not enough is being done to assist in the replacement of the devices.